Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism

[1]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.

[2]  Michael Jones,et al.  Reduced hippocampal CA2, CA3, and dentate gyrus activity in asymptomatic people at genetic risk for Alzheimer's disease , 2010, NeuroImage.

[3]  Arne D. Ekstrom,et al.  Family history of Alzheimer's disease and hippocampal structure in healthy people. , 2010, The American journal of psychiatry.

[4]  Arne D. Ekstrom,et al.  Advances in high-resolution imaging and computational unfolding of the human hippocampus , 2009, NeuroImage.

[5]  G. Alexander,et al.  Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease , 2009, Proceedings of the National Academy of Sciences.

[6]  B. Dickerson,et al.  The cortical signature of prodromal AD , 2009, Neurology.

[7]  Norbert Schuff,et al.  Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls , 2009, NeuroImage.

[8]  Arne D. Ekstrom,et al.  Correlation between BOLD fMRI and theta-band local field potentials in the human hippocampal area. , 2009, Journal of neurophysiology.

[9]  Norbert Schuff,et al.  Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T , 2008, NeuroImage.

[10]  Paul M. Thompson,et al.  Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers , 2008, NeuroImage.

[11]  Kaarin J Anstey,et al.  Total and regional gray matter volume is not related to APOE*E4 status in a community sample of middle-aged individuals. , 2008, The journals of gerontology. Series A, Biological sciences and medical sciences.

[12]  Christine Van Broeckhoven,et al.  Molecular genetics of Alzheimer's disease: An update , 2008, Annals of medicine.

[13]  J. M. Gatt,et al.  The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades , 2007, Biological Psychology.

[14]  Deanna Greenstein,et al.  Cortical morphology in children and adolescents with different apolipoprotein E gene polymorphisms: an observational study , 2007, The Lancet Neurology.

[15]  Richard J. Caselli,et al.  Correlations Between Apolipoprotein E ε4 Gene Dose and Whole Brain Atrophy Rates , 2007 .

[16]  R. Mayeux,et al.  Hippocampal and entorhinal atrophy in mild cognitive impairment , 2007, Neurology.

[17]  A. Toga,et al.  Tracking Alzheimer's Disease , 2007, Annals of the New York Academy of Sciences.

[18]  Kiralee M. Hayashi,et al.  3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. , 2006, Brain : a journal of neurology.

[19]  G. Alexander,et al.  Correlations between apolipoprotein E ε4 gene dose and brain-imaging measurements of regional hypometabolism , 2005 .

[20]  Gregory G. Brown,et al.  fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease , 2005, Neurology.

[21]  R. R. Sturrock,et al.  The Human Nervous System , 2004 .

[22]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Henry Rusinek,et al.  Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. , 2003, Radiology.

[24]  Joel Schwartz,et al.  Apolipoprotein E Genotype Predicts 24-Month Bayley Scales Infant Development Score , 2003, Pediatric Research.

[25]  Kiralee M. Hayashi,et al.  Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.

[26]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[27]  J. Gilbert,et al.  Defective neuronal sprouting by human apolipoprotein E4 is a gain‐of‐negative function , 2002, Journal of neuroscience research.

[28]  P M Thompson,et al.  Unfolding the human hippocampus with high resolution structural and functional MRI , 2001, The Anatomical record.

[29]  D. Delis,et al.  Improved memory functioning and frontal lobe maturation between childhood and adolescence: A structural MRI study , 2001, Journal of the International Neuropsychological Society.

[30]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[31]  Stephen A. Engel,et al.  Application of Cortical Unfolding Techniques to Functional MRI of the Human Hippocampal Region , 2000, NeuroImage.

[32]  J. Mazziotta,et al.  Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  R. McKay,et al.  Restoring production of hippocampal neurons in old age , 1999, Nature Neuroscience.

[34]  E G Tangalos,et al.  Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease , 1998, Annals of neurology.

[35]  H. Duvernoy,et al.  The Human Hippocampus: Functional Anatomy, Vascularization and Serial Sections with MRI , 1997 .

[36]  G. Glover,et al.  Retinotopic organization in human visual cortex and the spatial precision of functional MRI. , 1997, Cerebral cortex.

[37]  H. Wiśniewski,et al.  In Vivo Structural Studies of the Hippocampus in Normal Aging and in Incipient Alzheimer's Disease a , 1996, Annals of the New York Academy of Sciences.

[38]  H. Braak,et al.  Close-meshed prevalence rates of different stages as a tool to uncover the rate of Alzheimer's disease-related neurofibrillary changes , 1995, Neuroscience.

[39]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[40]  C. P. Hughes,et al.  A New Clinical Scale for the Staging of Dementia , 1982, British Journal of Psychiatry.

[41]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[42]  HERMAN BUSCHKE,et al.  Evaluating storage, retention, and retrieval in disordered memory and learning , 1974, Neurology.

[43]  D. Dooley.  Book Review: Atlas of the Human Brain , 1971 .

[44]  Michael E Phelps,et al.  Influence of cognitive status, age, and APOE-4 genetic risk on brain FDDNP positron-emission tomography imaging in persons without dementia. , 2009, Archives of general psychiatry.

[45]  Daniel Bandy,et al.  Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. , 2007, The American journal of psychiatry.

[46]  Peter Boesiger,et al.  Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. , 2007, Cerebral cortex.

[47]  Kewei Chen,et al.  Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  David Wechsler,et al.  Wechsler Memory scale. , 2005 .

[49]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.